Semaglutide: FDA publishes warning amid reports of patients overdosing

The US Food and Drug Administration (FDA) has published a warning to the public and healthcare providers after receiving reports that patients are overdosing on semaglutide, with some requiring hospital admission.1

FDA said the overdose reports it has received were related to “dosing errors involving compounded semaglutide injectable products dispensed in multiple dose vials.” It warned that in some instances, patients …